SCHEMBL7423015

SCHEMBL7423015

Cc1[nH]nc(C=C2C(=O)Nc3ccccc32)c1Cl

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 5/20 0.60
GSK3B P49841 2/20 0.59
ALK Q9UM73 3/20 0.56
TLK2 Q86UE8 1/20 0.51
NPC1 O15118 3/20 0.51
KMT2A Q03164 3/20 0.51
MAPT P10636 2/20 0.51
TDP1 Q9NUW8 2/20 0.51
GAA P10253 1/20 0.51
MEN1 O00255 2/20 0.50
LMNA P02545 2/20 0.50
PDGFRB P09619 2/20 0.50
DYRK1A Q13627 1/20 0.50
ALDH1A1 P00352 1/20 0.50
POLB P06746 1/20 0.50
THRB P10828 1/20 0.50
ALOX12 P18054 1/20 0.50
EGFR P00533 1/20 0.50
ERBB2 P04626 1/20 0.50
IGF1R P08069 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5728834 0.76 TLK2 (0.61) KDRGSK3BALKTLK2NPC1
SCHEMBL6001442 0.76 GSK3B (0.51) KDRGSK3BALKTLK2NPC1
SCHEMBL578229 0.76 CDK5 (0.58) KDRGSK3BALKTLK2MAPT
SCHEMBL5728833 0.76 TLK2 (0.61) KDRGSK3BALKTLK2NPC1
SCHEMBL578228 0.76 CDK5 (0.58) KDRGSK3BALKTLK2MAPT
SCHEMBL6001444 0.76 GSK3B (0.51) KDRGSK3BALKTLK2NPC1
SCHEMBL5475086 0.75 KDR (1.00) KDRGSK3BALKNPC1KMT2A
SCHEMBL5475085 0.75 KDR (1.00) KDRGSK3BALKNPC1KMT2A
SCHEMBL6000975 0.74 TLK2 (0.62) KDRGSK3BALKTLK2NPC1
SCHEMBL6000971 0.74 TLK2 (0.62) KDRGSK3BALKTLK2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5883116-A ANTITUMOR AGENTS AND ENZYME INHIBITORS SUGEN, INC. (US) 1999-03-16 US disclosed
EP-0769947-A4 INDOLINONE COMPOUNDS FOR THE TREATMENT OF DISEASE SUGEN INC (US) 1998-09-30 EP disclosed
EP-0769947-A1 INDOLINONE COMPOUNDS FOR THE TREATMENT OF DISEASE Sugen, Inc. (US) 1997-05-02 EP disclosed
WO-1996040116-A1 INDOLINONE COMPOUNDS FOR THE TREATMENT OF DISEASE SUGEN, INC. (US) 1996-12-19 WO disclosed